Apriani, D.W., Rismayanti, Wahiduddin. 2013. Faktor Risiko Kejadian Penyakit Kusta di Kota Makasar. Skripsi . Makasar: Fakultas Kesehatan Masyarakat Universitas Udayana.
Bakker, I.M., Hatta, M., Kwenang, A., Mosseveld, P.V., Faber, W.R., Klatser, P.R., Oskam, L. 2006. Risk Factor for Developing Leproy-a Population-Based Cohort Study in Indonesia. Lepr Rev;77:48-61.
Bartley, J., Camargo, C. A. 2013.Vitamin D and Infection. In: Gombart, A. F. Vitamin D: Oxidative Stress, Immunity, and Aging. United State: CRC press.p.323-51.
Bilke, D.D. 2014.Vitamin D Metabolism, Mechanism of Action, and Clinical Applications. Chemistry and Biology; 21(3): 319-29.
Bryceson, A, Pfaltzgraff, R.E. 1990. Symptoms and Sign of Leprosy. In: Bryceson A, Pfaltzgraff RE. Leprosy, 3rd ed. London: Churchill Livingstone. p. 25-55.
Bryceson, A., Pfaltzgraff. R.E. 1990. Bryceson, A., Pfaltzgraff. R.E. Immunology. In: Leprosy. 3rd ed. London: Churchill Livingstone. p. 93-114.
Bryceson, A.A., Pfaltzgraff, R.E. 1990. Diagnosis of Leprosy. In: Bryceson A, Pfaltzgraff RE. Leprosy, 3rd ed. London: Churchill Livingstone.p.57-75. Chun, R.F., Liu, P.T., Modlin, R.L., Adams, J.S., Hewison, M. 2014. Impact of
Vitamin D on Immune Function: Lessons Learned from Genom-Wide Analysis. Frontiers in Physiology. (serial online), [cited 2015 Jul. 10]. Available from: doi:10.3389/fphys.2014.00151.
Christakos, S., Ajibade, D.V., Dhawan, P., Fechner, A.J., Mady, L.J. 2010. Vitamin D: Metabolism. Endocrinol Metab Clin North Am; 39(2): 243-53. Dahlan, M.S. 2013. Besar Sampel dan Cara Pengambilan Sampel Dalam
Penelitian Kedokteran dan Kesehatan. Edisi ke-3. Jakarta: Salemba Medika.p.35-48.
DeLuca, H.F. 2013. History of the Discovery of Vitamin D and Its Active Metabolits. BoneKey Reports 3; 479. Doi:10.1038/bonekey.2013.213. Depkes RI. 2014. Profil Kesehatan Indonesia. Pusat Data dan Informasi. [cited
2015 Aug. 10]. Available from: depkes.go.id.
Desikan, K.V. 2003. Multy Drug Regimen in Leprosy and Its Impact on Prevalence of the Disease. MJAFI; 59: 2-4.
Dinas Kesehatan Propinsi Bali. 2015. Profil Kesehatan Propinsi Bali. Diakses dari:www.depkes.go.id/PROPINSI_2015/17_Profil_Kes.Prov.Bali_2015.p df (diakses tanggal 12 Februari 2016).
Dusso, A.S., Brown, A.J., Slatopolsky, E. 2005. Vitamin D. Am J Physiol Renal Physiol; 289: 8-28.
Edfelt, K., Liu, P.T., Chun R., Fabri, M., Schenk, M., Wheelwright, M. 2010. T-cell cytokines differentially controlhuman monocyte antimicrobial adaptations. Proc. Natl.Acad. Sci. USA 107, 22593-98. Cited on: [2015 Aug. 15]. Available from: doi:10.1073/pnas.1011624108.
Fabri, M., Stenger, S., Shin, D., Yuk, J.M., Liu, P.T., Realegeno, S. 2011. Vitamin D is Required for IFN-gamma-mediated antimycrobial activity of human macrophages. Sci.Transl. Med. 3, 104ra102. Cited on: [2016 April. 15]. Available from: doi: 10.1126/sci-translamed.3003045.
Goulart, L. R., Goulart, I. M. B. 2008. Leprosy Pathogenetic Background; A Review and Lessons From Other Mycobacterial Disease. Arch Dermatol Res;1-15.
Goulart, M.B., Souza, D.O.B., Marquez, C.R., Pimenta, V. L., Goncalves, M.A., Goulart, L.R. 2008. Risk and Protective Factors for Leprosy Development Determined by Epidemiological Surveillance of Household Contacts. Clinical and Vaccine Immunnology;15(1):101-05.
Gupta, V. 2012. Vitamin D: Extra Skeletal Effects. Journal of Medication Nutrition and Neutraceuticals; 1(1):17-26.
Handog, E.B., Gabriel, T.G., Co, C.C. 2011. Leprosy in the Philippines: a Review. Int. J. Dermatol; 50: 573–81.
Hawthorne, G. M., Thickett, D. R. 2011.Vitamin D and Tuberculosis. JPMI; 29(3):185-87.
Infodatin, 2015. Pusat Data dan Informasi Kementrian Kesehatan Republik Indonesia. Kusta. p. 1-7.
Jo, E.K., Shin, D.M., Modlin, R. L. 2013.Vitamin D and Human Innate Immunity. In: Gombart, A. F. Vitamin D, Oxidative Stress, Immunity, and Aging. New York: CRC Press. p. 223-39.
Kumar, B., Dogra, S. 2010. Case Definition and Clinical Type. In: Kar H.K., Kumar, B. IAL Texbook of Leprosy. India: Jaypee. p.152-66.
Lastoria, J.C. 2014. Leprosy: Review of the Epidemiological, Clinical, and Etiopathogenic Aspect-Part 1. An Bras Dermatol; 89(2): 205-18.
Liu, P.T., Stenger S., Li H., Wenzel, I., Tan, B.H., Krutzik, S.R., Ochoa, M.T., Schauber, J., Wu, K., editors. Toll-like Receptors Triggering of a Vitamin D Mediated Anti-Microbial Response. Science.2006;311:1770-3.
Luong, K.V.Q., Nguyen, L.T.H. 2012. The Role of Vitamin D ini Leprosy. The American Journal of the Medical Sciences; 343(6): 471-82.
Mahapatra, S., Crick, D.C., McNeil, M. R., Brennan, P. J. 2008. Unique Structural Features of the Peptidoglycan of Mycobacterium leprae. Jurnal of Bacteriology; 190(2): 655-61.
Madiyono, B., Moeslichan, S. Sastrosamoro, S., Budiman, I., Purwanto, S.H. 2010. Perkiraan Besar Sampel. Dalam: Sudigdo, S., Sofyan, I., penyunting. Dasar-Dasar Metodelogi Penelitian Klinis. Edisi ke-3, cetakan kedua. Jakarta: Sagung Seto. p. 301-30.
Mahajan,V. 2013. Smear in Leprosy: Lest We Forget It. Indian J Lepr;85:77-83. Mandal, D., Reja, A.H.H., Biswas, N., Bhattacharyya, P., Patra, P.K.,
Bhattacharyya, B.2015. Vitamin D Receptor Expression Levels Determine the Severity and Complexity of Disease Progression among Leprosy Reaction Patients.New Microbe and New Infect;6:35-9.
Maria C., 2008. “Analisis Faktor Risiko Kejadian Kusta (Studi Kasus di Rumah Sakit Kusta Donorejo Jepara)” (Skripsi). Semarang: Universitas Negeri Semarang.
Modlin. R.L. 2010. The Innate Immune Response in Leprosy. Curr Opin Immunol; 22(1): 48-54.
Montoya, D., Cruz, D., Teles, R.S.M., Lee, D. J., Ochoa, M.T., Kritzik, S. R., Chun, R., Schenk, M., Zhang, X., Ferguson, B.G., Burdick, A.E., Sarno, E.N., Rea, T.H., Hewison, M., Adams, J.S., Cheng, G., Modlin, R. 2009. Divergence of Macrophage Phagocytic and Antimicrobial Programs in Leprosy. Cell Host Microbe;6(4):343-53.
Norman, A.W. 2008. From Vitamin D to Hormone D: Fundamentals of the Vitamin D Endocrine System Essential for Good Health. Am J Nutr; 88: 491s-9s.
Northern Territory Goverment. 2010. Guidelines for the Control of Leprosy in the Northern Territory. Department of Health and Family.p.1-55.
Pike, J. W., Meyer, M. B., Lee, S. M. 2011.Vitamin D Receptor: Biochemical, Molecular, Biological, and Genomic Era Investigation. In: Feldman, D., Pike, J. W., Adams, J. S. Vitamin D. 3rd ed. London: Elsevier.p.97-137. Rees, R.J.W., Young, D.B. 1994.The Mycrobiology of Leprosy. In: Hasting, R.C.,
Opromolla, D.V.A. Leprosy. 2nd ed. London: Churchill Livingstone. p. 49-86.
Sales, A.M., Ponce de Leon, A., Duppre, N.C., Hacker, M., Nery, J.A.C., Sarno, E.N., Penna, M.L.F. 2011.Ploss Neglected Tropical Diseases:5(3) e1013 [2016 July. 04]. Available at: doi:10.1371/journal.pntd.0001013.t002. Santos, V.S., Teles de Mendonca Neto. P., Raposo, O. F. F., Fakhouri, R., Reis, F.
P., Feitosa, V.L.C. 2013. Evaluation of Agreement Between Clinical and Histopathological Data for Classifying Leprosy. International Journal of Infectious Diseases, 17:e189-92.
Sekar, B. 2010. Bacteriological Aspect. In: Kar H.K., Kumar, B. IAL Texbook of Leprosy. India: Jaypee. p.87-99.
Shuler, F.D., Wingate, M.K., Moore, G.H., Giangarra, C. 2012. Sports Health Benefits of Vitamin D. Sports Health: 496-501
Spierings, E., De Boer, T., Zulianello, L., Ottenhoff, T. H. 2000. The Role of Schwann Cells, T Cells, and Mycobacterium leprae in the Immnunopathogenesis of Nerve Damage in Leprosy. Lepr Rev; 7: s121-9. Suzuki, K., Akama, T., Kawashima, A., Yoshihara, A., Yotsu, R.R., Ishii, N.
2012. Current Status of Leprosy: Epidemiology, Basic Science and Clinical Perspectives. J of Dermatol; 39: 121–29.
Talat, N., Perry, S., Parsonnet, J., Dawood, G., Hussain, R. 2010.Vitamin D Deficiency and Tuberculosis Progression. Emerg Infect Dis. 2010 May; 16(5): 853–55.
Teixeira, M.AG., Magalhaes da Silveira, V., Rodrigues de Franca, E. 2010. Characteristic of Leprosy Reaction in Paucibacillary and Multibacillary Individuals Attented at Two Refference Centers in Recife, Pernambuco.Revista de Sociadade Brasileira de Medicina Tropical;43(3);287-92.
Teles, R.M., Graeber, T.G., Krutzik, S.R., Montoya, D., Schenk,M., Lee, D.J. 2013. Type I Interferon Suppresses Type II Interferon-Triggered
Mycobacterial Responses. Science 339,1448-53 (serial online), cited on [2016 April. 05]. Available from: doi:10.1126/science.1233665.
Thakkar, S., Patel, S.V. 2014. Clinical Profile of Leprosy Patients: A Prospective study. Indian J Dermatol;59(2):158-62.
Thorat, D.M., Sharma, P. 2010. Epidemiology. In: Kar H. K., Kumar, B. IAL Texbook of Leprosy. India: Jaypee. p. 24-31.
Viswewaran, R.K., Lekha, H. 2015. Extraskeletal Effects and Manifestations of Vitamin D Deficiency. Indian J Endocrinology Metab; 17(4): 602-10. Widodo, A.A., and Menaldi, S.L. 2012. Characteristics of Leprosy Patients in
Jakarta. J Indon Med Assoc; 62(11): 423-27.
World Health Organization. 2015. Global Leprosy Update 2014: Need for Early Case Detection. WHO Weekly Epidemiological Record; 36(90): 461-76. Worobec, S.M. 2009.Treatment of Leprosy/Hansen's Disease in the Early 21st
Century. Dhermatol.Ter; 22: 518-37.
Yudianto, Didik, B. Boga, H., Titu, A. S. 2015. Pengendalian Penyakit. Dalam: Profil Kesehatan Republik Indonesia Tahun 2014: Jakarta. Kementerian Kesehatan Republik Indonesia. p. 134-68.
Youssef, D.A., Miller, C.W.T., El-Abbassi, A. M., Cutchins, D.C., Grant, W.B., Peiris, A. N.2011. Antimicrobial Implications of Vitamin D. Dermato- Endocrinology; 3(4): 220-9.